Wilentz Shareholder Michael F. Schaff has been selected by the American Health Lawyers Association (AHLA) as a member of its Fellows Coordinating Committee, a two-year leadership role effective July 1. Established in 2004, the AHLA Fellows program recognizes lifelong leaders in the health law legal community who “have distinguished themselves both in the practice of their health law knowledge and skills” and for their “distinctive service to the health law profession.” The Fellows Coordinating Committee recommends each year new Fellows, in addition to overseeing the program’s activities and involvement of Fellows in various AHLA initiatives.
A longtime AHLA member, Mr. Schaff became a Fellow in 2016. He has served as a member of the association’s Board of Directors, Executive and Finance Committees and as the Chair of its Physician Organizations Practice Group. Mr. Schaff also led the team planning for the AHLA Physicians and Hospital Law Institute held in 2014, 2015 and 2016 and chaired the program committee for AHLA Fundamentals held in 2012 and 2013. In addition, Mr. Schaff contributes to the development of health law and life sciences law as a member of the AHLA Journal of Health & Life Sciences Law Editorial Board. In 2018, the association presented him with the prestigious David J. Greenburg Service Award, for his “significant contributions to the growth and life of AHLA.”
At Wilentz, Mr. Schaff is co-chair of the firm’s Health Law, Corporate, and Cannabis Law practice groups, where he leads a team of top-ranked lawyers who regularly advise on legal issues facing the health law industry, as well as regulatory and operational issues involved in building, investing in, and growing of successful healthcare businesses. For over 30 years, Mr. Schaff has represented physicians, hospitals, clinically integrated networks, management service organization, ambulatory surgical centers, healthcare facilities and healthcare businesses of all sizes in connection with a broad range of strategic transactions, entity formation, regulatory compliance, contract agreements, and negotiations.
Throughout his career, Mr. Schaff has educated and influenced healthcare professionals and lawyers, having served as Adjunct Associate Professor at Rutgers Robert Wood Johnson Medical School (formerly UMDNJ), on the Advisory Board of Seton Hall Law School’s Center for Health & Pharmaceutical Law & Policy, and on Bloomberg Law's Health Law and Business Editorial Advisory Board. Mr. Schaff is a Trustee of the New Jersey State Bar Association, an Emeritus Director of its Health Law Section and co-chair of its Cannabis Law Committee.